StreetAlpha.app
Home › Stocks › SGRY

Surgery Partners, Inc. (SGRY)

Healthcare
$26.78
▲ +0.34%
LAST CLOSE · NOV 20

Surgery Partners operates outpatient surgical facilities and related care services across the United States. It last closed at $26.78 on Nov 20, up 0.34% on the day. The next earnings report for SGRY is expected around Mon, Mar 1, 2027, after the close. For the quarter ended Sep 2026, SGRY reported EPS of -$0.16 on revenue of $815.3M, with revenue down 0.8% from a year ago. Over its last 8 reports the stock moved an average of 5.9% the session after earnings. Over the last 12 months SGRY insiders bought $144K of stock on the open market and sold $1.3M, according to SEC Form 4 filings.

AI Auto Pilots
Is SGRY in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SGRY.

Key Stats

Last 12 months
Results
Revenue
$3.4B
+2.2% vs a year ago
Net income
−$87.0M
−2.6% margin
EPS (diluted)
−$0.67
Free cash flow
$202.8M
6.0% margin
Valuation
Market cap
$3.5B
130.9M shares
P/E
–
No P/E while losing money
Price to sales
1.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$354.5M
At Sep 30
Shareholder equity
$1.7B
Shares outstanding
130.9M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $2.2B$2.2BFY2021FY2022: $2.5B$2.5BFY2022FY2023: $2.7B$2.7BFY2023FY2024: $3.1B$3.1BFY2024FY2025: $3.3B$3.3BFY2025

From SGRY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Mar 1
Estimated date · After the close
Reported EPS
-$0.16
Quarter ended Sep 2026
Year ago EPS
-$0.18
Same quarter last year
Revenue
$815.3M
−0.8% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.86Dec '24Mar 2025: -$0.30Mar '25Jun 2025: -$0.02Jun '25Sep 2025: -$0.18Sep '25Dec 2025: -$0.11Dec '25Mar 2026: -$0.28Mar '26Jun 2026: -$0.12Jun '26Sep 2026: -$0.16Sep '26Latest -$0.16
Revenue by quarter
Dec 2024: $864.4MDec '24Mar 2025: $776.0MMar '25Jun 2025: $826.2MJun '25Sep 2025: $821.5MSep '25Dec 2025: $885.0MDec '25Mar 2026: $810.9MMar '26Jun 2026: $848.9MJun '26Sep 2026: $815.3MSep '26Latest $815.3M
How SGRY moved after its last 8 reports
Average move the session after a report ±5.9%
Nov 9, 2026After the close+1.1%
Aug 10, 2026Time not announced+2.7%
May 5, 2026Time not announced+0.4%
Mar 2, 2026After the close−12.3%
Nov 10, 2025Time not announced−25.4%
Aug 5, 2025Time not announced−0.3%
May 12, 2025Time not announced+5.0%
Mar 3, 2025Time not announced−0.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SGRYStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SGRY
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SGRY

Technical Analysis

SGRY · as of the Nov 20 close · updated each morning
Uptrend, overbought

The stock is 7% above its 20 day and 31% above its 50 day average. It is 42% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 84), overbought. The nearest support is the Pivot S1 at $26.61, and the nearest resistance the Pivot at $26.79.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 2.3%/day
Key levels
$27.2352 week high+1.7%
$27.23Swing high (Nov 9)+1.7%
$26.95Pivot R1+0.6%
$26.79Pivot+0.0%
$26.78Last close
$26.61Pivot S1−0.6%
$24.9720 day average−6.8%
$23.12Swing low (Nov 2)−13.7%
$18.5650 day average−30.7%
$16.87100 day average−37.0%
$15.41200 day average−42.5%
$11.4152 week low−57.4%
Indicators
RSI (14)84.40Overbought above 70Overbought
MACD2.55Below its signal lineBearish
Stochastic89.9Near the top of its rangeOverbought
ADX (14)71.7Strong uptrend
Williams %R-10.8Oversold below −80, overbought above −20Overbought
CCI (20)69.0Oversold below −100, overbought above 100Neutral
Rate of change+15.4%Change over 10 sessionsBullish
ATR (14)$0.61Typical daily range, 2.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for SGRY

What happened before

See how SGRY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SGRY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SGRY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SGRYHow many large options trades hit SGRY, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

SGRY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲107 buying vs 85 selling
  • ▼Held by funds -5.4 pts
  • ▲Funds holding +2
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding191189+1.1%
In funds' top 1035−40.0%
Held by funds115.2%120.6%−5.4 pts
New / increased36 / 7135 / 720.0%
Reduced / sold out53 / 3251 / 27+9.0%
Put/call ratio1.150.11+927.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SGRY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SGRY Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$144K1 buy · 1 insider
Sold$1.3M11 sales · 6 insiders
2026-03 sold $1.3M2026-08 bought $144KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 18Teresa DeLucaDirectorBuy10,000$14.35$144K
Mar 16Jason Eric EvansCEOSale20,400$12.47$254K
Mar 16David T DohertyCFOSale8,867$12.50$111K
Mar 13Marissa BrittenhamChief Strategy OfficerSale3,657$12.54$46K
Mar 13Danielle BurkhalterChief Human Resources OfficerSale3,469$12.83$45K
Mar 12Jennifer BaldockChief Admin & Dev OfficerSale5,798$13.17$76K
Every insider buy and sale for SGRY over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SGRY insider trades →

From SEC Form 4 filings by SGRY's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGRY is in one of them and how their past SGRY trades turned out.

SGRY in the AI portfolios
Loading…

SGRY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SGRY in an article yet. Here's the latest on the wider market.

SGRY in the news

About Surgery Partners

Surgery Partners operates a national network of surgical facilities across the United States. Its facilities include outpatient surgery centers, surgical hospitals, anesthesia services, urgent care clinics and physician practices, with most focused on planned procedures that do not require a hospital stay. Its patients are mainly covered by private insurance and government programs such as Medicare. The company is based in Brentwood, Tennessee.

Headquarters
Brentwood, TN